Autumn has already begun in the Northern Hemisphere, so vaccination campaigns against seasonal viruses will soon begin. Without a doubt, the most well-known of these is flu vaccinealthough this is from COVID-19 It has also gained a lot of publicity for obvious reasons. Despite its more than obvious importance, vaccination rates in 2023-2024 over 65 years old in Spain it was the lowest in the last 4 seasons. This was not something exclusive to the territory of Spain. Other countries faced the same problem. But there may be a solution. It is believed that these figures can improve with home vaccination. For this reason, the US FDA gave the green light for the first time administering the flu vaccine at home.
We are talking about FluMistflu vaccine in aerosol formatdeveloped AstraZenecaIt has been sold in the US since 2003, but only one person could use it. medical organizationHowever, the rules are different now.
At the moment, the US is the only country that will implement this measure. But who knows, if it proves effective, maybe it will be what other countries need to increase? vaccination level.
FluMist: The Flu Vaccine That Can Now Be Given at Home
Americans who want to get FluMist at home will have to purchase it through online pharmacy. There will be some information requested for the purchase that will be verified before the product is shipped. This will confirm that the purchaser is indeed eligible to receive the flu vaccine.
Once that is done, all that remains is to wait for the package to arrive to administer this flu vaccine in aerosol format. This is a useful format for many reasons. Logically, the first is comfort and ease of use. But that’s not all.
The vaccine is sprayed directly onto nostrils. This is an advantage because this is the main route of entry for the flu virus. Therefore, immunity will start to develop from there.
What does the vaccine contain?
This flu vaccine has a classic format because it contains a weakened form of a live influenza virusIt is completely safe, as it has been used without problems for over 20 years.
Mainly recommended for people with age from 2 to 49 yearsso in principle it will not solve the problem of declining vaccination rates among people over 65. However, if the effectiveness of the format and its adherence are confirmed, other options can be developed.

At the moment, the American Society of Pediatrics recommends it especially for children. The fact that parents can do it at home will be a good initiative, as it reduces the stress that medical centers often cause for children. This can certainly be applicable to other countries.
But for now, we’ll have to wait and see how this flu vaccine goes. It’s the one the US has chosen, so we’ll be watching it closely. Any help in immunizing more vulnerable groups is small.
Source: Hiper Textual
